IRIS Accounts Production v23.4.0.336 11843032 director 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118430322022-06-30118430322023-06-30118430322022-07-012023-06-30118430322021-06-30118430322021-07-012022-06-30118430322022-06-3011843032ns15:EnglandWales2022-07-012023-06-3011843032ns14:PoundSterling2022-07-012023-06-3011843032ns10:Director12022-07-012023-06-3011843032ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3011843032ns10:SmallEntities2022-07-012023-06-3011843032ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3011843032ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3011843032ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3011843032ns10:FullAccounts2022-07-012023-06-3011843032ns10:OrdinaryShareClass12022-07-012023-06-3011843032ns10:RegisteredOffice2022-07-012023-06-3011843032ns5:CurrentFinancialInstruments2023-06-3011843032ns5:CurrentFinancialInstruments2022-06-3011843032ns5:Non-currentFinancialInstruments2023-06-3011843032ns5:Non-currentFinancialInstruments2022-06-3011843032ns5:ShareCapital2023-06-3011843032ns5:ShareCapital2022-06-3011843032ns5:RetainedEarningsAccumulatedLosses2023-06-3011843032ns5:RetainedEarningsAccumulatedLosses2022-06-3011843032ns5:PlantMachinery2022-06-3011843032ns5:PlantMachinery2022-07-012023-06-3011843032ns5:PlantMachinery2023-06-3011843032ns5:PlantMachinery2022-06-3011843032ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3011843032ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-3011843032ns5:Secured2023-06-3011843032ns5:Secured2022-06-3011843032ns10:OrdinaryShareClass12023-06-30
REGISTERED NUMBER: 11843032 (England and Wales)















EUDAI CLINIC LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2023






EUDAI CLINIC LTD (REGISTERED NUMBER: 11843032)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3 to 5


EUDAI CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2023







DIRECTOR: Dr D Vichas





REGISTERED OFFICE: 4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR





REGISTERED NUMBER: 11843032 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
27-29 Lumley Avenue
Skegness
Lincolnshire
PE25 2AT

EUDAI CLINIC LTD (REGISTERED NUMBER: 11843032)

STATEMENT OF FINANCIAL POSITION
30 JUNE 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 905 1,149

CURRENT ASSETS
Stocks 4,029 7,860
Debtors 5 11,717 11,573
Cash at bank 3,342 4,694
19,088 24,127
CREDITORS
Amounts falling due within one year 6 142,141 118,126
NET CURRENT LIABILITIES (123,053 ) (93,999 )
TOTAL ASSETS LESS CURRENT LIABILITIES (122,148 ) (92,850 )

CREDITORS
Amounts falling due after more than one year 7 16,000 24,000
NET LIABILITIES (138,148 ) (116,850 )

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings (138,150 ) (116,852 )
SHAREHOLDERS' FUNDS (138,148 ) (116,850 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved and authorised for issue by the director and authorised for issue on 16 March 2024 and were signed by:





Dr D Vichas - Director


EUDAI CLINIC LTD (REGISTERED NUMBER: 11843032)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

1. STATUTORY INFORMATION

Eudai Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Plant and machinery - 20% reducing balance

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell and after making due allowance for obsolete and slow moving items.

Financial instruments
The company has chosen to adopt the FRS 102A in respect of financial instruments.

Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


EUDAI CLINIC LTD (REGISTERED NUMBER: 11843032)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The director intends to support the company for at least twelve months from the date of the approval of the financial statements, and accordingly consider it appropriate that these financial statements have been prepared on the going concern basis.

Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 July 2022
and 30 June 2023 2,225
DEPRECIATION
At 1 July 2022 1,076
Charge for year 244
At 30 June 2023 1,320
NET BOOK VALUE
At 30 June 2023 905
At 30 June 2022 1,149

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 9,825 6,000
Other debtors 1,892 5,573
11,717 11,573

EUDAI CLINIC LTD (REGISTERED NUMBER: 11843032)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 8,000 8,000
Trade creditors 6,020 8,970
Taxation and social security 221 -
Other creditors 127,900 101,156
142,141 118,126

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Bank loans 16,000 24,000

8. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 24,000 32,000

The Bounceback loan is secured by the UK Government.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
2 Ordinary 1 2 2

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The director has provided an interest free loan totalling £119,818 (2022: £94,768).